SCHEMBL1584922

SCHEMBL1584922

CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)NCCSSCCN

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 9/20 0.53
PPARG P37231 3/20 0.53
FABP2 P12104 2/20 0.53
SLC22A12 Q96S37 1/20 0.53
POLB P06746 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
MAPT P10636 3/20 0.49
ALDH1A1 P00352 3/20 0.49
USP2 O75604 2/20 0.49
HTT P42858 1/20 0.49
CNR1 P21554 4/20 0.48
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C19 P33261 3/20 0.48
LMNA P02545 2/20 0.48
MEN1 O00255 2/20 0.48
CYP2C9 P11712 2/20 0.48
KMT2A Q03164 2/20 0.48
ABCB11 O95342 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1584395 0.88 PPARA (0.60) PPARAPPARGFABP2SLC22A12POLB
SCHEMBL1583983 0.87 PPARA (0.51) PPARAPPARGFABP2SLC22A12POLB
SCHEMBL22221440 0.85 PPARA (0.56) PPARAPPARGFABP2SLC22A12POLB
SCHEMBL12707654 0.84 PPARA (0.55) PPARAPPARGFABP2SLC22A12POLB
SCHEMBL1584385 0.83 PPARA (0.54) PPARAPPARGFABP2SLC22A12POLB
SCHEMBL12707625 0.82 PPARA (0.53) PPARAPPARGFABP2SLC22A12POLB
SCHEMBL22221670 0.82 PPARA (0.62) PPARAPPARGFABP2SLC22A12POLB
SCHEMBL1585228 0.82 POLB (0.58) PPARAPPARGFABP2POLBTDP1
SCHEMBL1583796 0.81 PPARA (0.52) PPARAPPARGFABP2SLC22A12POLB
SCHEMBL23903315 0.81 PTGS2 (0.50) PPARAPPARGFABP2POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011044141-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2011-04-14 WO disclosed
WO-2011044141-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2011-04-14 WO disclosed
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 US disclosed
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 US disclosed
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES FABP1, PPARA, FABP4 PPARA 2/4885PPARG 6/4885FABP2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.